Product Description
Unlock next‑level regeneration and recovery with the BPC‑157 x TB‑500 (Blend) — a synergistic peptide combination formulated for researchers and athletes focused on enhanced soft tissue repair, reduced downtime, and improved recovery support. This blend combines two powerful peptides:
- BPC‑157 – a synthetic peptide studied for healing support, angiogenesis, and cytoprotection.
- TB‑500 – a thymosin beta‑4 peptide fragment known for promoting cell migration, tissue remodelling, and anti‑inflammatory response.
Together, they work through complementary pathways to support recovery in muscles, tendons, ligaments, joints, and more.
Key Features
✔ Synergistic Peptide Stack – Combines two research peptides for broader recovery pathways.
✔ Advanced Tissue Support – Aimed at enhancing repair and regeneration mechanisms.
✔ High‑Quality Formulation – Designed for stability and purity in research settings.
✔ Flexible Protocols – Suitable for different recovery goals and cycles.
Ingredients
- BPC‑157 (Body Protection Compound‑157) – 15‑amino‑acid peptide with regenerative and angiogenic properties.
- TB‑500 (Thymosin Beta‑4 Fragment) – Peptide supporting cell migration and tissue remodelling.
- Lyophilised peptide blend powder – Requires reconstitution before use.
Benefits
📌 Enhanced Tissue Recovery – Supports faster repair of muscles, tendons, ligaments, & soft tissue.
📌 Improved Healing Timelines – Encourages angiogenesis & circulation for efficient nutrient delivery.
📌 Reduced Inflammation – Helps modulate inflammatory responses in recovery cycles.
📌 Mobility & Flexibility Support – May assist joint and connective tissue function.
📌 Research‑Focused Peptide Stack – Ideal for advanced recovery studies and protocols.
Recommended Usage
Important: This product is marketed for research purposes only. Not approved for human therapeutic use. Always follow appropriate research protocols and safety standards.
Reconstitution & Administration:
- Mix with bacteriostatic water per vial instructions.
- Typical subcutaneous injection protocols revolve around daily dosing cycles.
General Protocol Example:
- First Phase: 600–1000 mcg total blend daily delivering balanced BPC‑157 & TB‑500 doses.
- Cycle Length: 4–8 weeks study periods with rest intervals afterwards.
Adjust based on your specific research design or recovery focus.
Stacking Options
Maximise your research outcomes by stacking BPC‑157 x TB‑500 (Blend) with other peptides known in recovery protocols such as:
- CJC‑1295 + Ipamorelin – for growth hormone modulation.
- GHK‑Cu – for tissue repair and anti‑inflammatory effects.
Always structure stacks based on safety data and research goals.
Safety & Precautions
⚠️ Not approved medicine – Peptides like BPC‑157 and TB‑500 are research peptides not licensed for clinical use in the UK or EU.
⚠️ Use sterile technique for reconstitution and injection.
⚠️ Follow all appropriate handling and disposal protocols.
⚠️ Consult qualified professionals before experiment design.
⚠️ Monitor for any adverse responses and discontinue if concerns arise.
Contraindications:
- Pregnancy & breastfeeding
- Active disease states
- Unmonitored self‑administration in humans
Research peptides require rigorous safety practices.
Why Buy From Us?
✅ Premium Quality & Purity Standards – Sourced with research‑grade specifications.
✅ UK‑Focused Compliance & Support – Clear guidance for UK research environments.
✅ Reliable Supplier Reputation – Trusted by laboratories and peptide enthusiasts.
✅ Fast Shipping & Secure Packaging – Ensures peptide stability upon receipt.
Reviews
There are no reviews yet.